Back to top

Call for Abstracts--Scleroderma Canada Congress

Deadline June 2, 2013

Hamilton, Ontario
September 27 & 28, 2013
Pre-Congress CIHR Café Scientifique September 26, 2013  

Scleroderma, also known as systemic sclerosis, is a progressive and chronic connective tissue disorder characterized by the over-production of collagen (body protein) causing thickening, hardening and scarring of the skin and internal organs. Scleroderma is often referred to as if it were a single disease, when in fact; it is really a symptom of a group of diseases that involve the irregular growth of collagen.

How can we address the whole patient rather than the disease?What is the role of a team-based approach? How do we identify and respect the patient's perspective? How can our health system focus less on symptoms and disease, and more on the patient who has them? What is the role of “care coordinators”? How do we ensure patients’questions, concerns, fears or anxieties are addressed?

Download the abstract submission form from

Please complete and return by email to Joanne D'Aoust ( at the LATEST on Sunday, June 2nd, 2013 at midnight.

Questions should be directed to: Dr. Suzanne S. Taillefer at